Mylan CEO Heather Bresch gives herself a rise as life-saving EpiPens prices are hiked | Daily Mail Online

 

Heather Bresch, the CEO of EpiPen company Mylan not only quadrupled the price of the life-saving allergy tool – she also started taking home 671 per cent more money, it has emerged.

 

  • Mylan bought the EpiPen rights in 2007, when it cost $56.64 per pen
  • In 2015, the allergy-curing device cost $317.82 per pen – 461 per cent up
  • In that same period its CEO’s pay went from $2,453,456 to $18,931,068 
  • Mylan stock increased from $13.29 in 2007 to a peak of $47.59 in 2016
  • But now Congress is asking why the life-saving items cost so much

The CEO of EpiPen company Mylan not only quadrupled the price of the life-saving allergy tool – she also started taking home 671 per cent more money, it has emerged.

Mylan is currently facing Congress scrutiny after its EpiPens increased in price from $56.64 per pen in 2007 to $317.82 in 2015 – an increase of 461 per cent.

But perhaps even more shocking is the even bigger increase in some Mylan execs’ wages in that period – including those of CEO Heather Bresch, whose total compensation raised from $2,453,456 to $18,931,068, NBC reported.

Read more: http://www.dailymail.co.uk/news/article-3755601/CEO-company-increased-price-life-saving-EpiPens-461-cent-saw-wages-going-2m-19m.html#ixzz4ICxbRU6h
Follow us: @MailOnline on Twitter | DailyMail on Facebook

 

Source: Mylan CEO Heather Bresch gives herself a rise as life-saving EpiPens prices are hiked | Daily Mail Online